Xavier Morató Arús studied Pharmacy at the Universitat de Barcelona. He obtained a Master degree on Neuroscience from the University of Barcelona in 2012. He joined our lab in September 2012, where he is now performing his Ph.D. training with a FPI Grant (Formación de Personal Investigador) from the Ministry of Economy and Competitiveness, under the supervision of Dr. Francisco Ciruela and Dr. Víctor Fernández-Dueñas. His work is focused on deciphering the role of the Parkinson related GPR37, also known as PAEL receptor, and looking for specific ligands for this orphan receptor. He is also studying the interaction of this receptor with adenosine, dopamine and glutamate in the Central Nervous System. He defended his thesis entitled "GPR37-ADENOSINE A2A RECEPTOR-RECEPTOR INTERACTION AS A NEW PHARMACOLOGICAL TARGET FOR PARKINSON’S DISEASE TREATMENT" the 30/9/2017. Currently, he is working in the project “Propelling sigma-1 receptor screening for ligands: biosensors and protein-protein interactions”.